Prestige BioPharma Limited (KRX:950210)
South Korea · Delayed Price · Currency is KRW 6,310.00
-280.00 (-4.25%)
Last updated: Jun 22, 2026, 1:37 PM KST
-47.20% (1Y)
| Market Cap | 79.21B -49.9% |
| Revenue (ttm) | 16.21B +87.1% |
| Net Income | -57.32B |
| EPS | -953.45 |
| Shares Out | 12.02M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 44,184 |
| Open | 6,590.00 |
| Previous Close | 6,590.00 |
| Day's Range | 6,300.00 - 6,590.00 |
| 52-Week Range | 6,140.00 - 20,000.00 |
| Beta | 0.42 |
| Analysts | Buy |
| Price Target | 40,000.00 (+533.91%) |
| Earnings Date | Sep 18, 2026 |